Alyeska Investment Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-451,146
Closed -$37.7M 694
2024
Q4
$37.7M Sell
451,146
-479,984
-52% -$40.1M 0.14% 177
2024
Q3
$68.1M Sell
931,130
-463,402
-33% -$33.9M 0.35% 100
2024
Q2
$95.5M Buy
1,394,532
+1,142,612
+454% +$78.3M 0.55% 46
2024
Q1
$17.4M Buy
251,920
+133,137
+112% +$9.21M 0.11% 219
2023
Q4
$8.51M Sell
118,783
-12,917
-10% -$925K 0.06% 270
2023
Q3
$6.86M Buy
131,700
+93,700
+247% +$4.88M 0.05% 315
2023
Q2
$2.41M Sell
38,000
-12,000
-24% -$760K 0.02% 376
2023
Q1
$2.71M Buy
+50,000
New +$2.71M 0.02% 325
2021
Q1
Sell
-218,473
Closed -$6.95M 833
2020
Q4
$6.95M Sell
218,473
-337,839
-61% -$10.7M 0.1% 230
2020
Q3
$14.3M Buy
556,312
+287,912
+107% +$7.39M 0.22% 147
2020
Q2
$6.89M Sell
268,400
-209,026
-44% -$5.37M 0.1% 231
2020
Q1
$7.34M Buy
+477,426
New +$7.34M 0.15% 156
2017
Q4
Sell
-548,955
Closed -$8.66M 512
2017
Q3
$8.66M Buy
+548,955
New +$8.66M 0.06% 240
2015
Q4
Sell
-50,000
Closed -$2M 463
2015
Q3
$2M Buy
50,000
+37,485
+300% +$1.5M 0.02% 325
2015
Q2
$400K Sell
12,515
-6,393
-34% -$204K ﹤0.01% 439
2015
Q1
$452K Sell
18,908
-38,945
-67% -$931K 0.01% 446
2014
Q4
$1.02M Sell
57,853
-2,142
-4% -$37.8K 0.02% 380
2014
Q3
$823K Sell
59,995
-65,498
-52% -$898K 0.02% 321
2014
Q2
$2.12M Sell
125,493
-69,070
-36% -$1.16M 0.05% 277
2014
Q1
$3.54M Buy
+194,563
New +$3.54M 0.1% 184